ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,894Medicare Part D Prescriptions Filled, Including Refills

Rank: 73 out of 1155

$440K Total Retail Price of All Prescriptions

Rank: 77 out of 1155

423 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 423 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

13% of this provider’s 423 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 6,245 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LEVOTHYROXINE SODIUM 421 312 1 2
HYDROCODONE-ACETAMINOPHEN 371 276 S3 2 4
AMLODIPINE BESYLATE 367 310 3 6
LISINOPRIL 330 280 4 1
PRAVASTATIN SODIUM 286 232 5 20
ATENOLOL 254 221 6 10
LOSARTAN POTASSIUM 215 142 7 18
HYDROCHLOROTHIAZIDE 204 146 8 9
GABAPENTIN 203 113 9 15
SIMVASTATIN 203 178 9 3
OMEPRAZOLE 197 108 11 5
ATORVASTATIN CALCIUM 189 145 12 12
ZOLPIDEM TARTRATE 149 137 13 21
CITALOPRAM HBR 148 99 14 19
TRAZODONE HCL 123 71 15 22
WARFARIN SODIUM 122 79 16 11
METOPROLOL TARTRATE 113 98 17 14
DIOVAN 102 102 18 74
FUROSEMIDE 101 60 19 8
LOVASTATIN 86 78 20 13
METFORMIN HCL 83 44 21 7
RANITIDINE HCL 81 50 22 33
ADVAIR DISKUS 80 41 23 35
POTASSIUM CHLORIDE 79 55 24 16
SERTRALINE HCL 78 47 25 24
PREDNISONE 76 60 26 40
COMBIVENT 66 33 27 103
GLIPIZIDE 66 53 27 44
METHADONE HCL 64 13 S2 29 50
ENALAPRIL MALEATE 63 60 30 66
CYMBALTA 62 36 31 46
METOPROLOL SUCCINATE 62 60 31 17
OXYCODONE HCL 62 21 S2 31 23
CYCLOBENZAPRINE HCL 61 28 R 34 38
LANTUS 61 45 34 39
ALENDRONATE SODIUM 60 60 36 25
PANTOPRAZOLE SODIUM 60 46 36 47
FLUTICASONE PROPIONATE 59 35 38 37
TRIAMTERENE-HCTZ 55 48 39 51
OXYCODONE-ACETAMINOPHEN 54 0 S2 40 45
GLIMEPIRIDE 53 24 41 43
MORPHINE SULFATE ER 53 18 S2 41 36
VENLAFAXINE HCL ER 53 27 41 68
PRAMIPEXOLE DIHYDROCHLORIDE 52 28 44 159
SPIRIVA 52 49 44 49
ZETIA 51 29 46 129
BUPROPION HCL SR 50 26 47 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 3, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.